ArticlePlastic and reconstructive surgery. Global open2025
Key Insights From a Decade of Breast Augmentation: Our 5 Critical Decisions in Breast Implant Selection.
Article in Plastic and reconstructive surgery. Global open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- GLP-1 Receptor Agonist-Associated Weight Loss and Aesthetic Breast Surgery: A Narrative Review and Experience-Based Recommendations for Plastic and Reconstructive Surgeons.Aesthetic surgery journal. Open forum · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast augmentation continues to rank among the most commonly performed procedures. A crucial factor in achieving successful outcomes lies in a methodical implant-selection system, a principle underscored by Tebbetts and Adams in their TEPID and High Five systems. We have revisited several factors during years of experience. Methods: Thorough preoperative consultations play a pivotal role, involving discussions on the patient's motivation for breast augmentation and their medical history. Subsequently, medical photographs are taken, and 5 critical breast measurements are recorded: sternal notch-nipple distance, base width of the breast, soft-tissue coverage of the implant, optimal implant selection based on volume and dimensions, and calculation of the neo-inframammary fold using the Pythagorean theorem. Our system goes beyond traditional approaches by offering patients the chance to preview the postoperative result through both bra sizers and 3-dimensional simulation. Shared decision-making is another integral aspect of our methodology, providing patients with a voice in the medical decision-making process. Results: During the period from 2009 to 2019, the senior author conducted primary breast augmentations on 716 patients, with follow-ups extending up to 3 years. Notably, 1.5% (11 patients) required reoperation, and only 0.03% (2 patients) underwent reoperation specifically for implant size exchange. Conclusions: Our system's strength lies in its reliance on straightforward tissue-based measurements and a commitment to incorporating patient preferences through interactive decision-making. We aim to contribute to the professional development of fellow plastic surgeons and residents by sharing our 5 critical decisions, confident in their potential value for enhancing their practice.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.